High ALDH1 activity is a better universal functional marker predictive of enrichment of chemoresistant BTICs as compared to CD44high/CD24low breast cancer stem-like cell markers that cannot be ubiquitously used to identify BTICs in all breast cancer subtypes [19]. This evidence concerns the gene ALDH1A1 and breast cancer.